FDA approves nasal spray for nocturnal polyuria
On March 3, the U.S. Food and Drug Administration (FDA) approved octiva (desmopressin acetate) nasal spray for adults with nocturnal polyuria. Read more
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.